Pregnancy and multiple sclerosis: Clinical effects across the lifespan

Ai Lan Nguyen, Alana Eastaugh, Anneke van der Walt, Vilija G. Jokubaitis

Research output: Contribution to journalReview ArticleResearchpeer-review

Abstract

Multiple sclerosis (MS) is commonly diagnosed in women of childbearing age. Having a greater understanding of the effects of pregnancy on the course of MS will lead to improved family-planning counselling for women. We found well-established evidence for a protective effect of pregnancy on relapse occurrence in historical cohorts. More recent studies suggest that the protective effect of pregnancy against relapse may be lost in those women with more active disease treated with high efficacy therapies. Furthermore, a strong body of evidence suggests that gravidity after diagnosis of MS does not lead to worse long-term outcomes. More contentious however, is whether pregnancy can delay a first episode of demyelination or a confirmed diagnosis of MS. This review provides a detailed analysis of the literature relating to the clinical effects of pregnancy on MS outcomes across a woman's reproductive lifespan.

Original languageEnglish
Article number102360
Number of pages10
JournalAutoimmunity Reviews
Volume18
Issue number10
DOIs
Publication statusPublished - Oct 2019

Keywords

  • Disability
  • Gravidity
  • Multiple sclerosis
  • Parity
  • Pregnancy
  • Relapse

Cite this

@article{11a68e8d167a4ffa81df5c2fca44fccc,
title = "Pregnancy and multiple sclerosis: Clinical effects across the lifespan",
abstract = "Multiple sclerosis (MS) is commonly diagnosed in women of childbearing age. Having a greater understanding of the effects of pregnancy on the course of MS will lead to improved family-planning counselling for women. We found well-established evidence for a protective effect of pregnancy on relapse occurrence in historical cohorts. More recent studies suggest that the protective effect of pregnancy against relapse may be lost in those women with more active disease treated with high efficacy therapies. Furthermore, a strong body of evidence suggests that gravidity after diagnosis of MS does not lead to worse long-term outcomes. More contentious however, is whether pregnancy can delay a first episode of demyelination or a confirmed diagnosis of MS. This review provides a detailed analysis of the literature relating to the clinical effects of pregnancy on MS outcomes across a woman's reproductive lifespan.",
keywords = "Disability, Gravidity, Multiple sclerosis, Parity, Pregnancy, Relapse",
author = "Nguyen, {Ai Lan} and Alana Eastaugh and {van der Walt}, Anneke and Jokubaitis, {Vilija G.}",
year = "2019",
month = "10",
doi = "10.1016/j.autrev.2019.102360",
language = "English",
volume = "18",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "10",

}

Pregnancy and multiple sclerosis : Clinical effects across the lifespan. / Nguyen, Ai Lan; Eastaugh, Alana; van der Walt, Anneke; Jokubaitis, Vilija G.

In: Autoimmunity Reviews, Vol. 18, No. 10, 102360, 10.2019.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Pregnancy and multiple sclerosis

T2 - Clinical effects across the lifespan

AU - Nguyen, Ai Lan

AU - Eastaugh, Alana

AU - van der Walt, Anneke

AU - Jokubaitis, Vilija G.

PY - 2019/10

Y1 - 2019/10

N2 - Multiple sclerosis (MS) is commonly diagnosed in women of childbearing age. Having a greater understanding of the effects of pregnancy on the course of MS will lead to improved family-planning counselling for women. We found well-established evidence for a protective effect of pregnancy on relapse occurrence in historical cohorts. More recent studies suggest that the protective effect of pregnancy against relapse may be lost in those women with more active disease treated with high efficacy therapies. Furthermore, a strong body of evidence suggests that gravidity after diagnosis of MS does not lead to worse long-term outcomes. More contentious however, is whether pregnancy can delay a first episode of demyelination or a confirmed diagnosis of MS. This review provides a detailed analysis of the literature relating to the clinical effects of pregnancy on MS outcomes across a woman's reproductive lifespan.

AB - Multiple sclerosis (MS) is commonly diagnosed in women of childbearing age. Having a greater understanding of the effects of pregnancy on the course of MS will lead to improved family-planning counselling for women. We found well-established evidence for a protective effect of pregnancy on relapse occurrence in historical cohorts. More recent studies suggest that the protective effect of pregnancy against relapse may be lost in those women with more active disease treated with high efficacy therapies. Furthermore, a strong body of evidence suggests that gravidity after diagnosis of MS does not lead to worse long-term outcomes. More contentious however, is whether pregnancy can delay a first episode of demyelination or a confirmed diagnosis of MS. This review provides a detailed analysis of the literature relating to the clinical effects of pregnancy on MS outcomes across a woman's reproductive lifespan.

KW - Disability

KW - Gravidity

KW - Multiple sclerosis

KW - Parity

KW - Pregnancy

KW - Relapse

UR - http://www.scopus.com/inward/record.url?scp=85070285281&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2019.102360

DO - 10.1016/j.autrev.2019.102360

M3 - Review Article

C2 - 31401345

AN - SCOPUS:85070285281

VL - 18

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 10

M1 - 102360

ER -